May 2023 | Media
News & Announcements
May 2023 | Blog
May 2023 | Statement
May 10, 2023 – Today, in a landmark step for reproductive health, a joint FDA advisory committee voted unanimously to allow a birth control pill to be offered over the counter (OTC). The advisory committee vote reflects the decades of science showing that birth control pills are safe and...
May 2023 | Statement
We are thrilled to announce that Regina Tamés and Jay Zussman have joined the Ibis Board of Directors as Members at Large, and Fatimah Gifford is starting her term as Board Chair. Fatimah will be building on the work of former Board Chair Thoai Ngo to continue to advance racial justice and...
April 2023 | Statement
Cambridge, MA, April 10, 2023 – On Friday, April 7, 2023, a judge in a Texas federal court released a ruling in Alliance for Hippocratic Medicine v. FDA. The ruling places a stay on the FDA’s approval of mifepristone and seeks to remove it from the market nationwide. The same day...
March 2023 | Media
March 2023 | Statement
Insights from the World Population Review indicate that over 13 million children are born to women who are under 20 years old. Disturbingly, more than 90% of these births (about 12 million) occur in developing countries, with African countries topping the list. To address high rates of teenage...
March 2023 | Statement
Ibis Reproductive Health South Africa is proud to announce its partnership with Advocates For Youth (AFY) as the new Sub-Saharan Africa regional lead for the AMAZE Africa initiative, with the intention of amplifying ongoing efforts in the region to make comprehensive sexuality education resources...
March 2023 | Statement
The FDA announced today that an advisory committee meeting is scheduled for May 9 and 10 to review the first-ever application for an over-the-counter birth control pill. In July 2022, HRA Pharma announced it had submitted this application to the FDA to switch Opill, a progestin-only, daily birth...
October 2022 | Statement
We are frustrated and deeply disappointed by the FDA’s delay of the advisory committee meeting to discuss the application to move a progestin-only birth control pill over the counter (OTC). Birth control pills are safe and effective, and over-the-counter availability would expand equitable...
August 2022 | Statement
(Johannesburg, South Africa) – Ibis Reproductive Health, South Africa office is excited to announce a partnership with AMAZE.org , a project of Advocates for Youth implemented in collaboration with organizations around the world. AMAZE.org harnesses the power of digital media to provide...
July 2022 | Media